Page 22 - JCTR-11-4

Journal of Clinical and
Translational Research Hidden cancer after VTE

11. Van Es N, Le Gal G, Otten HM, et al. Screening for doi: 10.1016/j.thromres.2009.04.012
occult cancer in patients with unprovoked venous 21. Carrier M, Le Gal G, Tao H, et al. Should we screen
thromboembolism: A systematic review and meta- patients with unprovoked venous thromboembolism for
analysis of individual patient data. Ann Intern Med. occult cancers? A pilot study. Blood Coagul Fibrinolysis.
2017;167:410-417.
2010;21:709-710.
doi: 10.7326/M17-0868
doi: 10.1097/MBC.0b013e32833c3714
12. Nordström M, Lindblad B, Anderson H, Bergqvist D, 22. Rieu V, Chanier S, Philippe P, Ruivard M. Systematic
Kjellström T. Deep venous thrombosis and occult malignancy: screening for occult cancer in elderly patients with venous
An epidemiological study. BMJ. 1994;308(6933):891-894.
thromboembolism: A prospective study. Intern Med J.
doi: 10.1136/bmj.308.6933.891 2011;41:769-775.
13. Page MJ, Moher D, Bossuyt PM, et al. PRISMA 2020 doi: 10.1111/j.1445-5994.2011.02448.x
explanation and elaboration: Updated guidance and 23. Van Doormaal FF, Terpstra W, Van Der Griend R, et al.
exemplars for reporting systematic reviews. BMJ. Is extensive screening for cancer in idiopathic venous
2021;372:n160.
thromboembolism warranted? J Thromb Haemost.
doi: 10.1136/bmj.n160 2011;9(1):79-84.
14. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of doi: 10.1111/j.1538-7836.2010.04101.x
reports of randomized clinical trials: Is blinding necessary? 24. Rondina MT, Wanner N, Pendleton RC, et al. A pilot study
Control Clin Trials. 1996;17(1):1-12.
utilizing whole body 18 F-FDG-PET/CT as a comprehensive
doi: 10.1016/0197-2456(95)00134-4 screening strategy for occult malignancy in patients with
15. Wells GA, Shea B, O’Connell D, et al. The Newcastle-Ottawa unprovoked venous thromboembolism. Thromb Res.
Scale (NOS) for Assessing the Quality of Non-Randomized 2012;129:22-27.
Studies in Meta-Analysis. Available from: URL: https://www. doi: 10.1016/j.thromres.2011.06.025
ohri.ca/programs/clinical_epidemiology/oxford.htm [Last 25. Alfonso A, Redondo M, Rubio T, et al. Screening for occult
accessed on 2023 Nov 01].
malignancy with FDG-PET/CT in patients with unprovoked
16. Piccioli A, Lensing AW, Prins MH, et al. Extensive venous thromboembolism. Int J Cancer. 2013;133(9):2157-2164.
screening for occult malignant disease in idiopathic venous
thromboembolism: A prospective randomized clinical trial. doi: 10.1002/ijc.28229
J Thromb Haemost. 2004;2(6):884-889. 26. Jara-Palomares L, Otero R, Jimenez D, et al. Development
of a risk prediction score for occult cancer in patients with
doi: 10.1111/j.1538-7836.2004.00720.x
VTE. Chest. 2017;151(3):564-571.
17. Carrier M, Lazo-Langner A, Shivakumar S, et al. Screening
for occult cancer in unprovoked venous thromboembolism. doi: 10.1016/j.chest.2016.10.025
N Engl J Med. 2015;373(8):697-704. 27. Ihaddadene R, Corsi DJ, Lazo-Langner A, et al. Risk
factors predictive of occult cancer detection in patients
doi: 10.1056/NEJMoa1506623
with unprovoked venous thromboembolism. Blood.
18. Prandoni P, Bernardi E, Valle FD, et al. Extensive computed 2016;127(16):2035-2037.
tomography versus limited screening for detection of
occult cancer in unprovoked venous thromboembolism: doi: 10.1182/blood-2015-11-682963
A multicenter, controlled, randomized clinical trial. Semin 28. Bertoletti L, Robin P, Jara-Palomares L, et al. Predicting the
Thromb Hemost. 2016;42(8):884-890. risk of cancer after unprovoked venous thromboembolism:
External validation of the RIETE score. J Thromb Haemost.
doi: 10.1055/s-0036-1592335
2017;15(11):2184-2187.
19. Robin P, Le Roux PY, Planquette B, et al. Limited
screening with versus without (18)F-fluorodeoxyglucose doi: 10.1111/jth.13842
PET/CT for occult malignancy in unprovoked venous 29. Rosell A, Lundström S, Mackman N, Wallen H, Thalin C.
thromboembolism: An open-label randomised controlled A clinical practice-based evaluation of the RIETE score
trial. Lancet Oncol. 2016;17(2):193-199. in predicting occult cancer in patients with venous
thromboembolism. J Thromb Thrombolysis. 2019;
doi: 10.1016/S1470-2045(15)00480-5
48(1):111-118.
20. Jara-Palomares L, Rodríguez-Matute C, Elías-Hernández T,
et al. Testing for occult cancer in patients with pulmonary doi: 10.1007/s11239-019-01822-z
embolism: Results from a screening program and a two-year 30. Kraaijpoel N, Van Es N, Raskob GE, et al. Risk Scores for
follow-up survey. Thromb Res. 2010;125:29-33. occult cancer in patients with venous thromboembolism:

Volume 11 Issue 4 (2025) 16 doi: 10.36922/jctr.24.00069